82/100
Clariq Confidence™
Moderate approval likelihood
Confidence increased after readiness updates and payer criteria checks.
↑ +14 after readiness updates
Executive overview
Authorization Intelligence Dashboard
Monitor approval readiness, coverage risk, payer friction, and high-impact opportunities.
Cases analyzed
128
↑ 18%Ready to submit
41%
↑ 12%41%
Potential impact
$2.4M
per 1,000 casesTop Risk Case
Needs Review| Patient | Hemlibra / Aetna |
| Top gap | Bleeding logs missing |
| Next action | Attach prior treatment history |
Live Activity Feed
Lab threshold gap detected2 min ago
Readiness score updated8 min ago
Payer rule matched14 min ago
Recent Cases
| Case | Payer | Score | Status |
|---|---|---|---|
| IVIG | BCBS IL | 82 | Needs Review |
| Hemlibra | Aetna | 65 | High Risk |
| Octagam | Medicare | 91 | Ready |
Payer Updates
BCBS IL updated PA criteriaMay 28
Aetna updated step therapy policyMay 27
Cigna formulary updateMay 20
Coverage search
Search Coverage Rules
Check therapy, payer, plan, and diagnosis requirements before beginning authorization.
PA readiness analyzer
Validate Submission Readiness
Upload or review documentation against payer rules before submission.
Document Intake
Drop clinical notes, labs, and treatment history here
Clinical notes Met
IgG labs Missing
Prior therapy history Missing
Missing Documentation Alerts
IgG threshold evidence required
Prior therapy documentation recommended
Recommendation Engine
Attach IgG lab reportHigh impact
Include recurrent infection historyRequired
Denial intelligence
Learn From Outcomes
Identify denial patterns, documentation gaps, and payer-specific risks over time.
BCBS IL approvals drop 22% when IgG labs are missing.
Clariq surfaces high-impact denial patterns before teams submit.
Preventable denials
31%
Top gap
Labs
Best payer
Medicare
Time saved
2.4d
Denials Over Time
Top Denial Drivers
Missing labs38%
Prior therapy28%
Clinical notes21%
Enterprise view
Population-Level Authorization Intelligence
Scale coverage intelligence across therapies, payers, providers, and manufacturers.
Covered lives touched
48K
Therapies tracked
72
Avg denial risk
18%
Impact modeled
$8.7M
Market Scope
ProvidersPayersSpecialty PharmacyClariq Intelligence LayerRevenue CycleManufacturersOutpatient Sites
Therapy Performance
| Therapy | Approval | Top Gap |
|---|---|---|
| IVIG | 82% | Labs |
| Hemlibra | 65% | History |
| Octagam | 91% | Billing |
Workflow positioning
Clariq Intelligence Layer
Clariq intercepts before submission to strengthen authorization requests and improve approval outcomes.
Intake
Documentation
Clariq
Submission
Outcome
Clariq intercepts before submission
Identifying gaps, improving documentation, and increasing approval confidence.
Data Inputs
EHR & clinical data
Payer policies
Pharmacy systems
Claims & outcomes
Clariq Intelligence
Readiness scoring
Coverage logic
Gap detection
Next-best actions
Outputs
Prior auth submission
Appeals
Revenue cycle
Approval outcomes